Hologic Inc. (Nasdaq: HOLX) announced a delay to request FDA approval which in turn delayed the launch of its mammography system. Shares of the diagnostics company plunged $3.60 to $12.00.
Hologic Delays Mammography System Approval
May 05, 2009 at 13:31 PM EDT
